弯曲杆菌RE-CmeABC外排泵通道特征与氟苯尼考耐药增强机制
本研究通过分子建模与CAVER程序预测弯曲杆菌CmeB及耐药增强变体RE-CmeB的氟苯尼考外排通道,鉴定出P1为最优外排通道及关键瓶颈残基。突变实验证实Q87和K89为非保守关键位点,RE-CmeB的P1通道已进化为功能特化的主导外排通路,从而增强耐药性。
要点
- P1通道为氟苯尼考外排最优通道,瓶颈残基包括S615、S616、Q87、T614、K89、S47和S84。
- Q87和K89为非保守突变,对外排功能影响尤为显著。
- RE-CmeB的P1通道功能特化、冗余最小,是其耐药增强的结构基础。
核心结论
- RE-CmeB介导的氟苯尼考耐药增强主要源于P1外排通道的功能特化。
研究设计与样本
- 采用分子建模方法构建氟苯尼考与野生型CmeB及RE-CmeB的复合物模型。
- 利用CAVER程序预测外排通道及瓶颈残基,并通过自然转化构建突变体。
- 通过抗菌药物敏感性试验和蓄积试验进行功能验证。
主要发现
- 鉴定出P1为氟苯尼考最优外排通道,其瓶颈残基为S615、S616、Q87、T614、K89、S47和S84。
- Q87和K89的突变为非保守突变,对外排功能影响尤为显著。
- 与11168-RE-CmeABC相比,MU-11168-RE-CmeABC(RE-CmeB突变体)的MIC下降8倍且氟苯尼考蓄积增加。
- RE-CmeB的P1通道已进化为主导且专一的外排通路,功能冗余最小。
关键数值与推荐
- MU-11168-RE-CmeABC较11168-RE-CmeABC的MIC下降8倍,氟苯尼考蓄积增加。
临床怎么用
- Q87和K89可作为开发针对多重耐药弯曲杆菌外排泵抑制剂的候选靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aims to elucidate the molecular mechanism of enhanced florfenicol resistance mediated by the resistance-enhanced RE-CmeABC in Campylobacter, with a focus on the evolution of its efflux function. MATERIALS AND METHODS: The complex models of FFC with wild-type CmeB and RE-CmeB are constructed by molecular modelling methods, and the efflux channels and corresponding bottleneck residues are predicted by CAVER program. Then mutants are constructed on the basis of predicted amino acid residues by natural transformation and functional confirmation is performed by antimicrobial susceptibility testing and accumulation assay. RESULTS: Channel P1 is identified as the optimal FFC efflux channel, and the specific residues composed are illustrated. The corresponding bottleneck residues are S615, S616, Q87, T614, K89, S47 and S84. Among them, mutations of Q87 and K89 are non-conserved, having a particularly pronounced effect on efflux function. Decreased (8-fold) MIC and increased FFC accumulation were observed in MU-11168-RE-CmeABC (with mutated RE-CmeB) compared with that in 11168-RE-CmeABC (with RE-CmeB), respectively, which verifies the predicted FFC efflux tunnel is reliable. This demonstrates that the P1 channel in RE-CmeB has evolved into a dominant and specialized extrusion pathway with minimal functional redundancy, fundamentally underpinning its enhanced resistance. CONCLUSIONS: Our findings reveal that the enhanced resistance is primarily due to a functional specialization of the P1 efflux channel in RE-CmeB. This elucidation, strongly supported by the concordance between computational predictions and experimental data, provides a mechanistic basis and high-value targets (Q87/K89) for the development of efflux pump inhibitors against multidrug-resistant Campylobacter.
引用
- Yao H, Li W, Chen M, et al. Characterization of efflux pump channel of florfenicol for resistance-enhancing variant RE-CmeABC in Campylobacter. J Antimicrob Chemother. 2026. PMID: 41830323. doi:10.1093/jac/dkag047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。